Nutrien’s new collective agreement with Unifor Local 922 members brings significant wage increases and benefits, potentially boosting employee morale and company operations, and sparking hope for a stock market rebound.
Key market trends and upcoming earnings reports, including Lumos Diagnostics Holdings Ltd’s 1H FY25 financial results on February 27, 2025, are expected to shape market sentiment and investor decisions.
Nutrien’s stock price has experienced significant fluctuations over the past year, with a 52-week high of 83.14 CAD and a low of 60.74 CAD, and valuation metrics indicating a price-to-earnings ratio of 18.0321 and a price-to-book ratio of 1.03365.